Vimarsana
Biggest News Aggregation in the World

Page 5 - Trinity Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trinity Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trinity Biotech Today - Breaking & Trending Today

Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results - Vimarsana News

Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results

DUBLIN, Ireland, March 28, 2024 -- Trinity Biotech plc , a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, will report financial...

Trinity Biotech (NASDAQ:TRIB) Earns Buy Rating from Analysts at StockNews.com - Vimarsana News

Trinity Biotech (NASDAQ:TRIB) Earns Buy Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Trinity Biotech (NASDAQ:TRIB – Free Report) in a research note published on Saturday morning. The firm issued a buy rating on the stock. Trinity Biotech Price Performance NASDAQ:TRIB opened at $2.11 on Friday. Trinity Biotech has a 1-year low of $1.85 and a 1-year high of $6.20. The firm’s […]

Source: wkrb13.com
Global Adult Hemoglobinopathy Testing Market to Reach - Vimarsana News

Global Adult Hemoglobinopathy Testing Market to Reach

Dublin, March 26, 2024 (GLOBE NEWSWIRE) -- The

Analysts' New Coverage for March 23rd (AACG, AAME, ADXS, AEY, AKTX, AMED, AP, APWC, ARTW, AVGR) - Vimarsana News

Analysts' New Coverage for March 23rd (AACG, AAME, ADXS, AEY, AKTX, AMED, AP, APWC, ARTW, AVGR)

Analysts’ new coverage for Saturday, March 23rd: StockNews.com started coverage on shares of ATA Creativity Global (NASDAQ:AACG). StockNews.com issued a sell rating on the stock. StockNews.com started coverage on shares of Atlantic American (NASDAQ:AAME). The firm issued a hold rating on the stock. StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS). The firm issued […]

Source: wkrb13.com
Trinity Biotech (NASDAQ:TRIB) Earns Buy Rating from Analysts at StockNews.com - Vimarsana News

Trinity Biotech (NASDAQ:TRIB) Earns Buy Rating from Analysts at StockNews.com

Research analysts at StockNews.com assumed coverage on shares of Trinity Biotech (NASDAQ:TRIB – Get Free Report) in a note issued to investors on Thursday. The firm set a “buy” rating on the stock. Trinity Biotech Stock Performance Shares of NASDAQ:TRIB opened at $2.23 on Thursday. The stock has a market capitalization of $16.99 million, a […]